New azithromycin gel shows promise in early absorption study
NCT ID NCT05796362
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how a new gel version of the antibiotic azithromycin is absorbed by the body compared to the standard pill. Eighteen healthy adults took the drug in different forms (oral gel, rectal gel, and standard pill) on separate days. The goal was to measure drug levels in the blood and check for any immediate side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICAL INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Leftover blood samples could unlock new medical discoveries
- La reunion health survey aims to uncover hidden disease patterns
- Hunting the genes that make severe infections worse
- Aging immune system under the microscope: study seeks clues to infection risk in seniors
- New DNA test could revolutionize diagnosis of eye infections
- Abandoned trial: could a platelet booster help aplastic anemia?